BlackRock, Inc.
- SEC CIK
- 0002012383
- Latest filing
- Aug 7, 2026
ENSC holding history
Ensysce Biosciences, Inc. in every 13F filed by BlackRock, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
ENSC overviewAll 13F holders of ENSCFull Q2 2026 holdings
- Shares (Q2 2026)
- 65
- Value
- $19
- % of portfolio
- <0.1%
- Quarters held
- 8
- Since Q3 2024
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 65 | $19 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2026 | 65 | $35 | <0.1% | 00.0% | Unchanged | Holders |
| Q4 2025 | 65 | $60 | <0.1% | 00.0% | Unchanged | Holders |
| Q3 2025 | 65 | $154 | <0.1% | 00.0% | Unchanged | Holders |
| Q2 2025 | 65 | $145 | <0.1% | 00.0% | Unchanged | Holders |
| Q1 2025 | 65 | $166 | <0.1% | +1+1.6% | Added | Holders |
| Q4 2024 | 64 | $521 | <0.1% | −911−93.4% | Reduced | Holders |
| Q3 2024 | 975 | $234 | <0.1% | – | No prior filing | Holders |